Social distancing as a strategy to prevent respiratory virus infections

Jenkins, Christine; Sunjaya, Anthony Paulo

doi:10.1111/resp.13990

Cited by 5 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…respirátory na tvár na zmiernenie šírenia SARS-CoV-2. Aj podľa Jenkins, Sunjaya (2021), má sociálny dištanc a najmä nosenie masiek, potenciál znížiť exacerbácie vírusu v oveľa širšom kontexte. Výsledky štúdií naznačujú, že dôsledná a dobre komunikovaná informovanosť o COVID-19, vedie k individuálne lepšiemu prijatiu opatrení; umývania rúk, nosenia masiek a sociálneho dištancovania a môže byť účinnou stratégiou na zmiernenie a oddialenie epidémie (Teslya, et al, 2020;Wang, et al, 2020).…”

Section: Výsledky a Diskusiaunclassified

Public Health Protection in the Context of the Covid-19 Pandemic

Šupínová¹,

Bartošík²

2022

Osetrovatelske perspektivy

View full text Add to dashboard Cite

Section: Výsledky a Diskusiaunclassified

Public Health Protection in the Context of the Covid-19 Pandemic

Šupínová¹,

Bartošík²

2022

Osetrovatelske perspektivy

View full text Add to dashboard Cite

“…High-titre convalescent plasma did not improve survival or other outcome in patients hospitalized with COVID-19, 55 but early administration appeared useful in reducing the progression of COVID-19 in mildly ill infected older adults. 56 Vaccination Vaccination, in addition to community-wide interventions such as mask-wearing and social distancing, 57 is pivotal in the battle against COVID-19. Standard vaccination of BNT162b2 (Pfizer-BioNTech), AZD1222 (Oxford AstraZeneca), mRNA-1273 (Moderna) and CoronaVac (Sinovac) all offer high vaccine effectiveness against the ancestral SARS-CoV-2 strain and the Delta variant.…”

Section: Pharmacological Optionsmentioning

confidence: 99%

“…Vaccination, in addition to community‐wide interventions such as mask‐wearing and social distancing, 57 is pivotal in the battle against COVID‐19. Standard vaccination of BNT162b2 (Pfizer‐BioNTech), AZD1222 (Oxford AstraZeneca), mRNA‐1273 (Moderna) and CoronaVac (Sinovac) all offer high vaccine effectiveness against the ancestral SARS‐CoV‐2 strain and the Delta variant 58–62 .…”

Section: Covid‐19mentioning

confidence: 99%

Contemporary Concise Review 2021: COVID‐19 and other respiratory infections

Chan

Hui

2022

Respirology

View full text Add to dashboard Cite

Summary of key points Bats are likely the primary source of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Minks are highly susceptible to infection by SARS‐CoV‐2. Transmission from asymptomatic individuals was estimated to account for over 50% of all transmissions of coronavirus disease 2019 (COVID‐19) cases. SARS‐CoV‐2 is evolving towards more efficient aerosol transmission. Remdesivir, baricitinib, tocilizumab and dexamethasone are frequently used for the treatment of patients with respiratory failure due to COVID‐19. There is a rising incidence of non‐tuberculous Mycobacterium pulmonary disease globally, with a higher prevalence in Asian countries than in the Western world. Protracted bacterial bronchitis is a common cause of chronic productive cough in childhood. Re‐emergence of respiratory syncytial virus may occur after the relaxation of infection control measures and the reopening of borders during COVID‐19 pandemic.

show abstract

“…The potential value of NPI such as face coverings, hand sanitization and social distancing may be of particular interest in the exacerbation‐prone COPD population in the post‐pandemic era 22 . On the other hand, COPD patients may be particularly vulnerable to negative consequences of NPIs such as ‘stay at home’ orders.…”

Section: Copd and Covid‐19 Infectionmentioning

confidence: 99%